Literature DB >> 19398911

Schnyder corneal dystrophy.

Jayne S Weiss1.   

Abstract

PURPOSE OF REVIEW: The present review of Schnyder corneal dystrophy (SCD) corrects the misconceptions in the published literature about this disease. Understanding the clinical findings facilitates diagnosis of the dystrophy. RECENT
FINDINGS: Retrospective case series of 115 affected individuals from 34 SCD families identified since 1989 reports the clinical findings in a large cohort and the long-term visual morbidity of SCD. The configuration of the progressive corneal clouding is predictable on the basis of age and, contrary to many older publications, only 54% of affected patients were found to have corneal crystals. Penetrating keratoplasty was reported in 20 of 37 (54%) patients of at least 50 years and 10 of 13 (77%) patients of at least 70 years. Best corrected visual acuity 1 year prior to penetrating keratoplasty in 15 eyes (nine patients) ranged from 20/25 to 20/400 including seven eyes with other ocular disorders. Best corrected visual acuity in the remaining eight eyes was 20/25 to 20/70. These patients often complained of glare preoperatively, which most likely resulted from light scattering from the corneal cholesterol.
CONCLUSION: The literature on SCD must be changed to reflect new information about the disease. When present, corneal crystals facilitate disease diagnosis but the examiner must be aware that they are only present 54% of the time. Although scotopic vision remains good until old age, disproportionate loss of photopic vision with frequent complaints of glare necessitates penetrating keratoplasty in the majority of patients over 50 years of age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398911     DOI: 10.1097/ICU.0b013e32832b753e

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  13 in total

1.  Clinical and pathological features of a non-crystalline form of Schnyder corneal dystrophy.

Authors:  Nicole Arnold-Wörner; David Goldblum; André R Miserez; Josef Flammer; Peter Meyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-14       Impact factor: 3.117

2.  [Bilateral disc-like corneal opacity before cataract extraction].

Authors:  J M Rohrbach; G Willmann; W Lisch
Journal:  Ophthalmologe       Date:  2011-11       Impact factor: 1.059

3.  [Discrete bilateral corneal deposits in a young woman].

Authors:  J M Rohrbach; B Sobolewska; K Helaiwa; W Lisch
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

4.  Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation.

Authors:  Xuejie Chen; Natsuko Furukawa; Da-Yun Jin; Yizhou Liu; Darrel W Stafford; Craig M Williams; Yoshitomo Suhara; Jian-Ke Tie
Journal:  FEBS J       Date:  2021-12-01       Impact factor: 5.622

5.  Schnyder Corneal Dystrophy in a Saudi Arabian Family with Heterozygous UBIAD1 Mutation (p.L121F).

Authors:  Huda Al-Ghadeer; Jawahir Y Mohamed; Arif O Khan
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

6.  A mutation in the UBIAD1 gene in a Han Chinese family with Schnyder corneal dystrophy.

Authors:  Chunyu Du; Ying Li; Lili Dai; Lingmin Gong; Chengcheng Han
Journal:  Mol Vis       Date:  2011-10-15       Impact factor: 2.367

7.  The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase.

Authors:  Marc M Schumacher; Rania Elsabrouty; Joachim Seemann; Youngah Jo; Russell A DeBose-Boyd
Journal:  Elife       Date:  2015-03-05       Impact factor: 8.140

8.  Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice.

Authors:  Youngah Jo; Jason S Hamilton; Seonghwan Hwang; Kristina Garland; Gennipher A Smith; Shan Su; Iris Fuentes; Sudha Neelam; Bonne M Thompson; Jeffrey G McDonald; Russell A DeBose-Boyd
Journal:  Elife       Date:  2019-02-20       Impact factor: 8.140

9.  Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase.

Authors:  Shi-You Jiang; Jing-Jie Tang; Xu Xiao; Wei Qi; Suqian Wu; Chao Jiang; Jiaxu Hong; Jianjiang Xu; Bao-Liang Song; Jie Luo
Journal:  PLoS Genet       Date:  2019-07-19       Impact factor: 5.917

10.  Clinical diversity in patients with Schnyder corneal dystrophy-a novel and known UBIAD1 pathogenic variants.

Authors:  Anna Sarosiak; Monika Udziela; Aneta Ścieżyńska; Dominika Oziębło; Anna Wawrzynowska; Jacek P Szaflik; Monika Ołdak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.